{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T20:29:57Z","timestamp":1764880197776,"version":"build-2065373602"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.ejps.2021.105820","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T19:04:33Z","timestamp":1616785473000},"page":"105820","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["In-silico screening for identification of potential inhibitors against SARS-CoV-2 transmembrane serine protease 2 (TMPRSS2)"],"prefix":"10.1016","volume":"162","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4377-372X","authenticated-orcid":false,"given":"Sagar","family":"Barge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3009-5915","authenticated-orcid":false,"given":"Dhananjay","family":"Jade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gokul","family":"Gosavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narayan Chandra","family":"Talukdar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jagat","family":"Borah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2021.105820_bib0001","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1-2","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"year":"2020","series-title":"TMPRSS2 inhibitors, Bromhexine, Aprotinin, Camostat and Nafamostat as potential treatments for COVID-19","author":"Azimi","key":"10.1016\/j.ejps.2021.105820_bib0002"},{"key":"10.1016\/j.ejps.2021.105820_bib0003","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1021\/jm901137j","article-title":"New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays","volume":"53","author":"Baell","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2021.105820_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105944","article-title":"Teicoplanin: an alternative drug for the treatment of COVID-19?","volume":"55","author":"Baron","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejps.2021.105820_bib0005","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.addr.2016.05.007","article-title":"BDDCS, the Rule of 5 and drugability","volume":"101","author":"Benet","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2021.105820_bib0006","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/B978-0-444-63951-6.00624-0","article-title":"SARS","author":"Berger","year":"2011","journal-title":"Encyclopedia Environ. Health"},{"key":"10.1016\/j.ejps.2021.105820_bib0007","doi-asserted-by":"crossref","first-page":"13363","DOI":"10.1128\/JVI.05300-11","article-title":"Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease","volume":"85","author":"Bertram","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.ejps.2021.105820_bib0008","doi-asserted-by":"crossref","first-page":"13363","DOI":"10.1128\/JVI.05300-11","article-title":"Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease","volume":"85","author":"Bertram","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.ejps.2021.105820_bib0009","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1021\/acs.jcim.9b00020","article-title":"BCL::MolAlign: Three-Dimensional Small Molecule Alignment for Pharmacophore Mapping","volume":"59","author":"Brown","year":"2019","journal-title":"J. Chem. Inf. Model"},{"key":"10.1016\/j.ejps.2021.105820_bib0010","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/pro.5560020916","article-title":"Verification of protein structures: patterns of nonbonded atomic interactions","volume":"2","author":"Colovos","year":"1993","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejps.2021.105820_bib0011","doi-asserted-by":"crossref","first-page":"D506","DOI":"10.1093\/nar\/gky1049","article-title":"UniProt: a worldwide hub of protein knowledge","volume":"47","author":"Consortium","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejps.2021.105820_bib0012","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2021.105820_bib0013","article-title":"Structure, function and variants analysis of the androgen-regulated <em>TMPRSS2<\/em>, a drug target candidate for COVID-19 infection","author":"David","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.ejps.2021.105820_bib0014","doi-asserted-by":"crossref","first-page":"W362","DOI":"10.1093\/nar\/gkl124","article-title":"ScanProsite: detection of PROSITE signature matches and ProRule-associated functional and structural residues in proteins","volume":"34","author":"de Castro","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejps.2021.105820_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117477","article-title":"Anti-HCV, nucleotide inhibitors, repurposing against COVID-19","volume":"248","author":"Elfiky","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.ejps.2021.105820_bib0016","doi-asserted-by":"crossref","DOI":"10.1002\/0471250953.bi0506s15","article-title":"Comparative protein structure modeling using Modeller","author":"Eswar","year":"2006","journal-title":"Curr. Protoc. Bioinformatics"},{"key":"10.1016\/j.ejps.2021.105820_bib0017","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/CM9.0000000000000797","article-title":"Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model","volume":"133","author":"Fan","year":"2020","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.ejps.2021.105820_bib0018","series-title":"The Proteomics Protocols Handbook","first-page":"571","article-title":"Protein Identification and Analysis Tools on the ExPASy Server","author":"Gasteiger","year":"2005"},{"key":"10.1016\/j.ejps.2021.105820_bib0019","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.ejps.2021.105820_bib0020","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.1128\/JVI.02232-10","article-title":"Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response","volume":"85","author":"Glowacka","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.ejps.2021.105820_bib0021","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/978-3-319-75474-1_4","article-title":"Priming Time: How Cellular Proteases Arm Coronavirus Spike Proteins","author":"Hoffmann","year":"2018","journal-title":"Activation of Viruses by Host Proteases"},{"key":"10.1016\/j.ejps.2021.105820_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ejps.2021.105820_bib0023","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1089\/omi.2009.0045","article-title":"MetaPocket: a meta approach to improve protein ligand binding site prediction","volume":"13","author":"Huang","year":"2009","journal-title":"Omics"},{"key":"10.1016\/j.ejps.2021.105820_bib0024","article-title":"Structural Basis of SARS-CoV-2 Spike Protein Priming by TMPRSS2","author":"Hussain","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.ejps.2021.105820_bib0025","first-page":"1","article-title":"Ligand-based pharmacophore modeling of TNF-\u03b1 to design novel inhibitors using virtual screening and molecular dynamics","author":"Jade","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejps.2021.105820_bib0026","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1002\/bip.360221211","article-title":"Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features","volume":"22","author":"Kabsch","year":"1983","journal-title":"Biopolymers"},{"key":"10.1016\/j.ejps.2021.105820_bib0027","first-page":"2006","article-title":"COVID-19 (Novel Coronavirus 2019) - recent trends","volume":"24","author":"Kannan","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ejps.2021.105820_bib0028","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1093\/bioinformatics\/btz976","article-title":"ChemBioServer 2.0: an advanced web server for filtering, clustering and networking of chemical compounds facilitating both drug discovery and repurposing","volume":"36","author":"Karatzas","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejps.2021.105820_bib0029","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1006\/jmbi.2000.4315","article-title":"Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes","volume":"305","author":"Krogh","year":"2001","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejps.2021.105820_bib0030","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1021\/ci500020m","article-title":"g_mmpbsa\u2014A GROMACS Tool for High-Throughput MM-PBSA Calculations","volume":"54","author":"Kumari","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejps.2021.105820_bib0031","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/BF00228148","article-title":"AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR","volume":"8","author":"Laskowski","year":"1996","journal-title":"J. Biomol. NMR"},{"key":"10.1016\/j.ejps.2021.105820_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112527","article-title":"A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir","volume":"201","author":"Liang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2021.105820_bib0033","doi-asserted-by":"crossref","unstructured":"Lipinski, C.A., Lombardo, F., Dominy, B.W., Feeney, P.J.J.A.d.d.r., 1997. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. 23, 3-25.","DOI":"10.1016\/S0169-409X(96)00423-1"},{"key":"10.1016\/j.ejps.2021.105820_bib0034","doi-asserted-by":"crossref","DOI":"10.1071\/MA20013","article-title":"COVID-19: a novel zoonotic disease caused by a coronavirus from China: what we know and what we don't","author":"Mackenzie","year":"2020","journal-title":"Microbiol. Aust."},{"key":"10.1016\/j.ejps.2021.105820_bib0035","doi-asserted-by":"crossref","first-page":"m4709","DOI":"10.1136\/bmj.m4709","article-title":"Covid-19: Moderna applies for US and EU approval as vaccine trial reports 94.1% efficacy","volume":"371","author":"Mahase","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.ejps.2021.105820_bib0036","doi-asserted-by":"crossref","first-page":"7001","DOI":"10.1073\/pnas.2002589117","article-title":"Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells","volume":"117","author":"Matsuyama","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejps.2021.105820_bib0037","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00683-18","article-title":"Middle East Respiratory Syndrome Coronavirus Spike Protein Is Not Activated Directly by Cellular Furin during Viral Entry into Target Cells","volume":"92","author":"Matsuyama","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.ejps.2021.105820_bib0038","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.virusres.2014.11.021","article-title":"Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis","volume":"202","author":"Millet","year":"2015","journal-title":"Virus Res."},{"key":"10.1016\/j.ejps.2021.105820_bib0039","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejps.2021.105820_bib0040","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.15585\/mmwr.mm6950e2","article-title":"The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine - United States, December 2020","volume":"69","author":"Oliver","year":"2020","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"10.1016\/j.ejps.2021.105820_bib0041","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2021.105820_bib0042","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1056\/NEJMp2032369","article-title":"FDA Approval of Remdesivir - A Step in the Right Direction","volume":"383","author":"Rubin","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2021.105820_bib0043","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1056\/NEJMe2034717","article-title":"SARS-CoV-2 Vaccination - An Ounce (Actually, Much Less) of Prevention","volume":"383","author":"Rubin","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2021.105820_bib0044","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1107\/S0907444904011679","article-title":"PRODRG: a tool for high-throughput crystallography of protein-ligand complexes","volume":"60","author":"Sch\u00fcttelkopf","year":"2004","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"10.1016\/j.ejps.2021.105820_bib0045","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1128\/JVI.02062-10","article-title":"A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry","volume":"85","author":"Shulla","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.ejps.2021.105820_bib0046","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1021\/acs.jcim.5b00559","article-title":"ZINC 15\u2013Ligand Discovery for Everyone","volume":"55","author":"Sterling","year":"2015","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejps.2021.105820_bib0047","doi-asserted-by":"crossref","first-page":"D364","DOI":"10.1093\/nar\/gku1028","article-title":"A series of PDB-related databanks for everyday needs","volume":"43","author":"Touw","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejps.2021.105820_bib0048","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1574-6976.2006.00032.x","article-title":"Human coronavirus NL63, a new respiratory virus","volume":"30","author":"van der Hoek","year":"2006","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.ejps.2021.105820_bib0049","doi-asserted-by":"crossref","unstructured":"Veber, D.F., Johnson, S.R., Cheng, H.-Y., Smith, B.R., Ward, K.W., Kopple, K.D.J.J.o.m.c., 2002. Molecular properties that influence the oral bioavailability of drug candidates. 45, 2615-2623.","DOI":"10.1021\/jm020017n"},{"key":"10.1016\/j.ejps.2021.105820_bib0050","article-title":"Genetic variants in TMPRSS2 and Structure of SARS-CoV-2 spike glycoprotein and TMPRSS2 complex","author":"Vishnubhotla","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.ejps.2021.105820_bib0051","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ejps.2021.105820_bib0052","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bbi.2020.04.046","article-title":"Current status of potential therapeutic candidates for the COVID-19 crisis","volume":"87","author":"Zhang","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.ejps.2021.105820_bib0053","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1093\/bioinformatics\/btr331","article-title":"Identification of cavities on protein surface using multiple computational approaches for drug binding site prediction","volume":"27","author":"Zhang","year":"2011","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejps.2021.105820_bib0054","doi-asserted-by":"crossref","DOI":"10.1038\/s41421-020-0153-3","article-title":"Network-based drug repurposing for novel coronavirus 2019-nCoV\/SARS-CoV-2","volume":"6","author":"Zhou","year":"2020","journal-title":"Cell Discov."},{"key":"10.1016\/j.ejps.2021.105820_bib0055","doi-asserted-by":"crossref","unstructured":"Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R.J.N.E.J.o.M., 2020. A novel coronavirus from patients with pneumonia in China, 2019.","DOI":"10.1056\/NEJMoa2001017"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098721001226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098721001226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:57:45Z","timestamp":1760529465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098721001226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":55,"alternative-id":["S0928098721001226"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2021.105820","relation":{},"ISSN":["0928-0987"],"issn-type":[{"type":"print","value":"0928-0987"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In-silico screening for identification of potential inhibitors against SARS-CoV-2 transmembrane serine protease 2 (TMPRSS2)","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2021.105820","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105820"}}